MSWA is proud to be funding this important West Australian research that will provide the first effective treatment to minimise the damage that occurs in the early phases of stroke.
Filter News Articles
MSWA recently announced the winners of the latest MSWA Mega Home Lottery’s $3.3M Grand Prize.
The MS Readathon is over for another year! The national amount raised was a record breaking $3.12 million!
A number of MSWA Customers with communication difficulties will soon be able to trial a device which will assist them to communicate more effectively, thanks to a generous $20K donation from Pharmacy 777.
The PBAC has recently made announcements regarding two MS treatments - Ocrelizumab (Ocrevus®) and Mayzent® (siponimod).
We contributed $2.1m to MSRA to form part of their $10.5m national boost towards MS research.
Throughout August, five-year-old Karla Anand is taking part in her first MS Readathon, reading as many books as she can to raise money for Western Australians living with neurological conditions – people like her mum, Maddy.
A national study funded by MSWA via Motor Neurone Disease Research Australia has confirmed the increased risk of prolonged grief, anxiety and depression for caregivers who have lost a loved one to motor neurone disease.
MSWA to build a new 20-unit High Support Accommodation Facility in Montario Quarter (Shenton Park).
The Perron Institute is continuing its recruitment of people with motor neurone disease (MND) for the pilot TONiC study, a project proudly supported by MSWA.